WHO releases US$1.5 million to fight diphtheria in Cox’s Bazar as probable cases exceed 1,500

IMT News Desk
IMT News Desk
· 2 min read

The World Health Organization has deployed additional staff and resources to respond to a rapidly spreading outbreak of diphtheria among Rohingya refugees in Cox’s Bazar, Bangladesh.

WHO has released US$1.5 million from its Contingency Fund for Emergencies to help finance scaling up of health operations in Cox’s Bazar over the next six months, in efforts to respond to an outbreak that has seen more than 1,500 probable cases, including 21 deaths.

“The Rohingya refugees are an extremely vulnerable population, with low routine vaccination coverage. WHO is applying a ‘no regrets’ policy when allocating resources to help prevent and protect communities from the spread of diphtheria and ensure that those who are sick receive critical care and treatment,” said Dr Roderico Ofrin, Regional Emergency Director, WHO South-East Asia Regional Office. “The funds released will be crucial to sustaining our efforts until we receive more support from donors for this response.”

Over the next 6 months, the funds will be used to support immunization activities; improve laboratory capacity, support community engagement, contact tracing and case management in health facilities through critical guidance as well as the provision of essential medicines and supplies.

In the past week, WHO has deployed additional experts, procured hospital beds to accommodate more patients in diphtheria treatment centres, provided  1,345 vials of lifesaving diphtheria anti-toxins and 300 000 doses of antibiotics, and is working with health authorities to support ongoing vaccination efforts for both children and health workers.

In addition to this, WHO is working with more than 80 health partners to improve access to essential life-saving primary and secondary health services in Cox’s Bazar.

For 2018, the health sector will request additional funding to help 1.2 million people living in refugee camps and temporary settlements.

Read Next

Akums Reports Strong Q4 FY26 Performance; EBITDA Surges 62%, Board Recommends Dividend
News
May 15, 2026

Akums Reports Strong Q4 FY26 Performance; EBITDA Surges 62%, Board Recommends Dividend

Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organisation (CDMO), has reported a robust financial performance for the fourth quarter and full year ended March 31, 2026, driven by strong growth in its core CDMO business and improved operational efficiencies. Q4 FY26: Profitability Outpaces Revenue Growth Akums posted an operating revenue of […]
Article by: IMT News Desk
Alembic Pharmaceuticals announces USFDA Tentative Approval for Darolutamide Tablets
News
May 14, 2026

Alembic Pharmaceuticals announces USFDA Tentative Approval for Darolutamide Tablets

Alembic Pharmaceuticals Limited (Alembic) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Darolutamide Tablets, 300 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Nubeqa Tablets, 300 mg, of Bayer HealthCare Pharmaceuticals Inc. (Bayer). Darolutamide is an androgen […]
Article by: IMT News Desk
Lilly launches Lormalzi® (Donanemab) for the treatment of early symptomatic Alzheimer’s Disease in India
News
May 14, 2026

Lilly launches Lormalzi® (Donanemab) for the treatment of early symptomatic Alzheimer’s Disease in India

Eli Lilly and Company (India) Pvt. Ltd. has announced the launch of Lormalzi® (donanemab, 350 mg/20 mL IV vial) in India, following marketing authorisation from the Central Drugs Standard Control Organization (CDSCO) for the treatment of Alzheimer’s disease with mild cognitive impairment or those in the mild dementia stage of disease. Lormalzi® is the first […]
Article by: IMT News Desk
Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement
News
May 14, 2026

Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement

Stryker and Max Smart Super Speciality Hospital, Saket, announced a strategic collaboration to advance surgeon training, clinical education, and patient care in robotic-arm-assisted joint replacement in India. As part of this collaboration, Max Smart Super Speciality Hospital, Saket, will serve as a training and education center for orthopaedics. The collaboration aims to support the evolving joint replacement ecosystem […]
Article by: IMT News Desk